Dr Lal Pathlabs Ltd Share Price (LALPATHLAB)
as on
| Source : NSE
Dr Lal Pathlabs Ltd Stock Performance
as on August 14, 2025 at 4:01 PM IST
Day's Low
Day's High
₹3,260₹3,365
2.62%
Downside
0.51%
Upside
52 Week's Low
52 Week's High
₹2,293.55₹3,653.9531.49%
Downside
9.14%
Upside
| Market Stats | |
| Previous Close | ₹3,295.40 |
| Open | ₹3,318.00 |
| Volume | 95.48K |
| Upper Circuit | ₹3,954.40 |
| Lower Circuit | ₹2,636.40 |
| Day's Low | ₹3,260 |
| Day's High | ₹3,365 |
| 52 Week Low | ₹2,293.55 |
| 52 Week High | ₹3,653.95 |
| Returns % | |
| 1 Month Return | + 12.56 % |
| 3 Month Return | + 19.88 % |
| 1 Year Return | + 1.43 % |
| 3 Year Return | + 34.67 % |
| 5 Year Return | + 74.92 % |
Dr Lal Pathlabs Ltd Stock Fundamentals & Key Indicators
Check Dr Lal Pathlabs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹28,046.37 Cr
Return on Equity (ROE)
24.65
PE Ratio (TTM)
54.37
Return on capital employed (ROCE)
29.14
Industry PE ratio
53.88
Beta (LTM)
0.39
P/B Ratio
9.71
Dividend Yield
0.97
PEG Ratio
3.46
Quarterly Earnings Growth YOY
24.3
EPS (TTM)
58.89
Sector
Healthcare
Book Value
259.92
Technical Analysis
Bullish
View Technical Analysis
Dr Lal Pathlabs Ltd Stock's Interest Amongst Investors
Dr Lal Pathlabs Ltd Stock Valuation
Track how Dr Lal Pathlabs Ltd P/E has moved over time to understand its valuation trends.
Dr Lal Pathlabs Ltd in the last 5 years
Lowest (37.51x)
November 16, 2018
Industry (53.88x)
August 14, 2025
Today (54.37x)
August 14, 2025
Highest (95.62x)
November 5, 2020
Today’s Price to Earnings Ratio: 54.37x
Dr Lal Pathlabs Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Dr Lal Pathlabs Ltd.
based on 25 analysts
64.00%
Buy
8.00%
Hold
28.00%
Sell
64% of analysts recommend a 'HOLD' rating for Dr Lal Pathlabs Ltd. Average target price of ₹3276.68
Source: S&P Global Market Intelligence
Dr Lal Pathlabs Ltd Share Price Target
Get share price movements and forecasts by analysts on Dr Lal Pathlabs Ltd.
Dr Lal Pathlabs Ltd price forecast by 25 analysts
Downside of-2.12%
High
₹4020
Target
₹3276.68
Low
₹2260
Dr Lal Pathlabs Ltd target price ₹3276.68, a slight downside of -2.12% compared to current price of ₹3347.8. According to 25 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Dr Lal Pathlabs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:25.25%
Forecast
Actual
Including amortisation and stock based compensations
Dr Lal Pathlabs Ltd EPS growth forecast
EPS estimate Q1, FY2027:23.37%
Forecast
Actual
Source: S&P Global Market Intelligence
Dr Lal Pathlabs Ltd Financial Results
Get the annual and quarterly financial summary of Dr Lal Pathlabs Ltd, including revenue, profit, loss and more.
Dr Lal Pathlabs Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Dr Lal Pathlabs Ltd.
Dr Lal Pathlabs Ltd Earnings Results
Dr Lal Pathlabs Ltd’s net profit jumped 24.44% since last year same period to ₹132.40Cr in the Q1 2025-2026. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated -14.47% fall in its net profits since last 3-months.
Read More about Earnings ResultsDr Lal Pathlabs Ltd Dividends July,2025
In the quarter ending June 2025, Dr Lal Pathlabs Ltd has declared dividend of ₹6.00 per share on 31 Jul 2025 - translating a dividend yield of 0.91%.
Read More about Dividends
Indices Featuring Dr Lal Pathlabs Ltd Stock
Check stock indices that include Dr Lal Pathlabs Ltd.
Dr Lal Pathlabs Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Dr Lal Pathlabs Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.79% | ||
| Foreign Institutions | 21.68% | ||
| Mutual Funds | 15.04% | 17.16 | |
| Retail Investors | 6.23% | 6.70 | |
| Others | 3.26% |
Dr Lal Pathlabs Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Dr Lal Pathlabs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 28,046.37 | 14.98% | 0.54 | 492 | 2,461 | |
| HOLD | 46,408.75 | 62.32% | 0.71 | 354 | 5,553 | |
| HOLD | 63,937.38 | 17.05% | 0.59 | 2,216 | 12,964 | |
| BUY | 10,818.99 | 13.97% | 0.65 | 119 | 547 | |
| BUY | 7,332.84 | 13.09% | 0.53 | 90 | 687 |
Dr Lal Pathlabs Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Dr Lal Pathlabs Ltd.
Dr Lal Pathlabs Declares Interim Dividend for 2025-2026 - 06 Aug, 2025
Dr Lal Pathlabs has announced an interim dividend of ₹6 per equity share for the fiscal year 2025-2026, with a record date of August 06, 2025.Dr Lal PathLabs Reports Strong Growth and Bullish Outlook - 01 Aug, 2025
Dr Lal PathLabs shows strong financial performance with a 24% rise in net profit and 11.28% increase in net sales for June 2025. Technical indicators suggest bullish momentum, while the CEO outlines growth strategies for fiscal 2026.Dr. Lal PathLabs Reports Strong Earnings and Dividend - 31 Jul, 2025
Dr. Lal PathLabs announced a 24% increase in net profit for June 2025, with net sales rising 19.87%. The Board recommended an interim dividend of Rs 6 per share, subject to shareholder approval.Dr. Lal Pathlabs Reports Strong Financial Performance - 25 Jul, 2025
Dr. Lal Pathlabs, India's largest diagnostics provider, reported a consolidated revenue of ₹24.61 billion and a net profit of ₹4.87 billion for the year ending March, reflecting over 11% growth. The company continues to innovate and expand its services.
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 5.84% to 6.23% in Jun 2025 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 12.84% to 15.04% in Jun 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 621.8 Cr → 697.9 Cr (in ₹), with an average increase of 5.5% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, LALPATHLAB stock has moved up by 12.6%
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 74.9% return, outperforming this stock by 73.5%
- NO EFFECT
Against Peers
In the last 3 years, Fortis Healthcare Ltd has given 218.9% return, outperforming this stock by 184.2%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 23.91% to 21.68% in Jun 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 53.91% to 53.79% in Jun 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 154.8 Cr → 132.4 Cr (in ₹), with an average decrease of 14.5% per quarter
About Dr Lal Pathlabs Ltd
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Revenue: ₹669.80Cr as on June 2025 (Q1 FY26)
Net Profit: ₹134.00Cr as on June 2025 (Q1 FY26)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| CEO | Arvind Lal |
| E-voting on shares | Click here to vote |
Mutual Funds that own Dr Lal Pathlabs Ltd Stock
Check out the Mutual Funds with significant holdings in Dr Lal Pathlabs Ltd.
FAQs
What is Dr Lal Pathlabs Ltd share price today?
Dr Lal Pathlabs Ltd share price today stands at ₹3347.8, Open: ₹3318, Previous Close: ₹3295.4, High: ₹3365, Low: ₹3260, 52 Week High: ₹3653.95, 52 Week Low: ₹2293.55 as on .
How to buy Dr Lal Pathlabs Ltd shares ?
To buy Dr Lal Pathlabs Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for LALPATHLAB or Dr Lal Pathlabs Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Dr Lal Pathlabs Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Dr Lal Pathlabs Ltd?
Today's traded volume of Dr Lal Pathlabs Ltd is 95.48K. Which means that 95.48K shares of Dr Lal Pathlabs Ltd were bought and sold on the stock market during today's trading session.
What is Dr Lal Pathlabs Ltd's market cap today?
Today's market capitalisation of Dr Lal Pathlabs Ltd is ₹28,046.37 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Dr Lal Pathlabs Ltd?
Dr Lal Pathlabs Ltd’s 52 week high is ₹3653.95 and 52 week low is ₹2293.55. The current share price of Dr Lal Pathlabs Ltd is ₹3347.8, which is -8.38% down from its 52 week high and 45.97% up from its 52 week low.